Cargando…

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses

Plasmacytoid dendritic cells (pDCs) chronically produce type I interferon (IFN-I) in autoimmune diseases, including systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). We report that the IRE1α-XBP1 branch of the unfolded protein response (UPR) inhibits IFN-α production by TLR7- or TLR9-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhary, Vidyanath, Ah Kioon, Marie Dominique, Hwang, Sung-Min, Mishra, Bikash, Lakin, Kimberly, Kirou, Kyriakos A., Zhang-Sun, Jeffrey, Wiseman, R. Luke, Spiera, Robert F., Crow, Mary K., Gordon, Jessica K., Cubillos-Ruiz, Juan R., Barrat, Franck J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441715/ https://www.ncbi.nlm.nih.gov/pubmed/36053251 http://dx.doi.org/10.1084/jem.20221085

Ejemplares similares

Innate sensing of viral infection by pDCs and regulation by IFN-α and HMGB1 of TRAIL expression on pDCs and NK cells
por: Saïdi, Héla, et al.
Publicado: (2014)

Phenotypic and functional alterations of pDCs in lupus-prone mice
por: Zhou, Zhenyuan, et al.
Publicado: (2016)

IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity
por: Lippens, Carla, et al.
Publicado: (2016)

Chemokines form nanoparticles with DNA and can superinduce TLR-driven immune inflammation
por: Du, Yong, et al.
Publicado: (2022)

Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
por: Laurent, Paôline, et al.
Publicado: (2022)

NK-pDC cross-talk leads to the generation of mTRAIL+IFN-α+cytotoxic pDCs following HIV-1 infection of pDCs. Consequences on the control of viral replication
por: Saïdi, Héla, et al.
Publicado: (2010)

Compare mDCs and pDCs between two distinct patients groups in acute HIV-1 infection
por: Jiao, Yanmei, et al.
Publicado: (2014)

Data on PRRSV infection promoted the subtype of porcine dendritic cells from mDCs to pDCs in vivo
por: Liu, Jinling, et al.
Publicado: (2016)

Extended Freeze-Dried BCG Instructed pDCs Induce Suppressive Tregs and Dampen EAE
por: Lippens, Carla, et al.
Publicado: (2018)

Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN
por: Shimizu, Kanako, et al.
Publicado: (2019)

Interferon-induced versus chemokine transcripts as lupus biomarkers
por: Crow, Mary K, et al.
Publicado: (2008)

New role for antigen-presenting activated pDCs in promoting Th17 cells and impacting antitumor immunity
por: Guéry, Leslie, et al.
Publicado: (2015)

Physical Exercise Induces Immunoregulation of TREG, M2, and pDCs in a Lung Allergic Inflammation Model
por: Fernandes, Paula, et al.
Publicado: (2019)

Lack of Association Between Sex Hormones, MDSCs, LDGs and pDCs in Males and Females With Systemic Lupus Erythematosus
por: Jones, Jessica M., et al.
Publicado: (2022)

Plasmacytoid Dendritic cells (pDCs) in HIV-infected and HIV/HCV-co-infected patients receiving successful treatment
por: Khokhlova, Olga, et al.
Publicado: (2014)

CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses
por: Monaghan, Katherine A., et al.
Publicado: (2023)

Neonatal Plasmacytoid Dendritic Cells (pDCs) Display Subset Variation but Can Elicit Potent Anti-Viral Innate Responses
por: Zhang, Xiaoming, et al.
Publicado: (2013)

Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs
por: Ouaguia, Laurissa, et al.
Publicado: (2020)

Emergence of IFN-alpha TRAIL-expressing killer pDCs (IKpDCs) as a consequence of a crosstalk with NK cells. Influence of HIV-1 infection and implication of HMGB1
por: Bras, Marlène, et al.
Publicado: (2012)

Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs
por: Ma, Shixin, et al.
Publicado: (2017)

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial
por: Spiera, Robert F, et al.
Publicado: (2011)

Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement—A new target for lupus treatment
por: Smith, Nikaïa, et al.
Publicado: (2019)

Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs)
por: Chen, Maosheng, et al.
Publicado: (2019)

Mutation in Irf8 Gene (Irf8(R294C) ) Impairs Type I IFN-Mediated Antiviral Immune Response by Murine pDCs
por: Das, Annesa, et al.
Publicado: (2021)

Interferon-alpha and angiogenic dysregulation in pregnant lupus patients destined for preeclampsia
por: Andrade, Danieli, et al.
Publicado: (2014)

Sedimentation and mobility of PDCs: a reappraisal of ignimbrites’ aspect ratio
por: Giordano, Guido, et al.
Publicado: (2017)

Relationships between IL-17(+) Subsets, Tregs and pDCs That Distinguish among SIV Infected Elite Controllers, Low, Medium and High Viral Load Rhesus Macaques
por: Khowawisetsut, Ladawan, et al.
Publicado: (2013)

BDCA1(+) cDC2s, BDCA2(+) pDCs and BDCA3(+) cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients
por: Sosa Cuevas, Eleonora, et al.
Publicado: (2020)

Applications of the European Parkinson’s Disease Association sponsored Parkinson’s Disease Composite Scale (PDCS)
por: Balestrino, Roberta, et al.
Publicado: (2019)

CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes
por: Yang, Chao, et al.
Publicado: (2022)

Ash clouds temperature estimation. Implication on dilute and concentrated PDCs coupling and topography confinement
por: Pensa, A., et al.
Publicado: (2019)

Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes
por: Girard, Pauline, et al.
Publicado: (2021)

A new tool for detection of type I interferon activation in systemic lupus erythematosus
por: Kirou, Kyriakos A, et al.
Publicado: (2010)

Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
por: Fu, Chen, et al.
Publicado: (2023)

Interferon-induced gene expression in systemic lupus erythematosus reflects previous exposure to interferon alpha and is associated with increased disease activity and autoreactivity against RNA-binding proteins
por: Kirou, KA, et al.
Publicado: (2004)

Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations
por: Mavragani, Clio P., et al.
Publicado: (2013)

Phase Evolution, Filler-Matrix Interactions, and Piezoelectric Properties in Lead Zirconate Titanate (PZT)-Filled Polymer-Derived Ceramics (PDCs)
por: Eichhorn, Franziska, et al.
Publicado: (2020)

Pure & crystallized 2D Boron Nitride sheets synthesized via a novel process coupling both PDCs and SPS methods
por: Yuan, Sheng, et al.
Publicado: (2016)

Improving Formation Conditions and Properties of hBN Nanosheets Through BaF(2)-assisted Polymer Derived Ceramics (PDCs) Technique
por: Matsoso, Boitumelo J., et al.
Publicado: (2020)

Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus
por: Gkrouzman, Elena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lreipd8asfm6q9bin5gj0g1eqh